Sartorius Stedim Biotech's market cap is currently ―. The company's EPS TTM is €1.763; its P/E ratio is ―; and it has a dividend yield of 0.35%. Sartorius Stedim Biotech is scheduled to report earnings on January 28, 2025, and the estimated EPS forecast is €0.98. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21
Income Statement	-
Total Revenue	$ 890.00M	$ 878.40M	$ 861.80M	$ 862.50M	$ 778.20M
Gross Profit	$ 473.10M	$ 461.00M	$ 445.90M	$ 454.50M	$ 403.80M
EBIT	$ 216.20M	$ 289.50M	$ 294.50M	$ 348.80M	$ -6.20M
EBITDA	$ 272.30M	$ 331.70M	$ 337.20M	$ 389.50M	$ 33.70M
Net Income Common Stockholders	$ 186.70M	$ 204.50M	$ 214.80M	$ 270.10M	$ -8.70M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 133.00M	$ 161.70M	$ 181.00M	$ 212.20M	$ 237.30M
Total Assets	$ 5.07B	$ 5.10B	$ 4.38B	$ 4.16B	$ 3.95B
Total Debt	$ 1.14B	$ 1.17B	$ 732.20M	$ 630.90M	$ 625.50M
Net Debt	$ 1.00B	$ 1.00B	$ 551.20M	$ 418.70M	$ 388.20M
Total Liabilities	-	-	-	-	-
Stockholders Equity	$ 2.45B	$ 2.27B	$ 2.05B	$ 1.92B	$ 1.66B
Cash Flow	-
Free Cash Flow	$ 77.70M	$ 36.60M	$ -24.60M	$ 92.00M	$ 27.30M
Operating Cash Flow	$ 219.60M	$ 145.40M	$ 78.10M	$ 169.20M	$ 165.30M
Investing Cash Flow	$ -148.00M	$ -584.60M	$ -103.90M	$ -121.00M	$ -137.30M
Financing Cash Flow	$ -105.60M	$ 424.00M	$ 9.80M	$ -107.50M	$ -36.70M

Currency in USD

Sartorius Stedim Biotech Earnings and Revenue History

Income Statement >

Sartorius Stedim Biotech Debt to Assets

Balance Sheet >

Sartorius Stedim Biotech Cash Flow

Cash Flow >

Sartorius Stedim Biotech Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing